How much cash does Aardvark Therapeutics, Inc. Common Stock generate?

Aardvark Therapeutics, Inc. Common Stock (AARD) generated -$61.7M in operating cash flow over the trailing twelve months.

Where does Aardvark Therapeutics, Inc. Common Stock's cash flow data come from?

Every line is extracted from Aardvark Therapeutics, Inc. Common Stock's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

Aardvark Therapeutics, Inc. Common Stock AARD Cash Flow Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	Q1 '26	Q4 '25	Q3 '25	Q2 '25	Q1 '25
Net income	-$21.59M-22.7%	-$17.6M-7.9%	-$16.32M-13.6%	-$14.37M-54.3%	-$9.31M-6.0%
Depreciation and amortization	$11K+10.0%	$10K0.0%	$10K-9.1%	$11K+120%	$5K-37.5%
Stock-based compensation	$2M+26.8%	$1.58M+5.4%	$1.5M+137%	$634K+172%	$233K+34.7%
Net cash from operating activities	-$18.87M-12.2%	-$16.81M-4.2%	-$16.13M-63.9%	-$9.84M+13.6%	-$11.39M-47.4%
Capital expenditures	——	$0-100%	$4K-95.6%	$91K—	$0-100%
Net cash from investing activities	$34.25M—	——	——	——	-$112.62M-847%
Net cash from financing activities	$4K-98.5%	$274K+60.2%	$171K—	$0-100%	$88.88M—
Net increase (decrease) in cash	$15.39M—	——	——	-$506K+98.6%	-$35.14M—

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

How much cash does Aardvark Therapeutics, Inc. Common Stock generate?: Aardvark Therapeutics, Inc. Common Stock (AARD) generated -$61.7M in operating cash flow over the trailing twelve months.
Where does Aardvark Therapeutics, Inc. Common Stock's cash flow data come from?: Every line is extracted from Aardvark Therapeutics, Inc. Common Stock's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.